Search

Your search keyword '"Motazacker, M."' showing total 35 results

Search Constraints

Start Over You searched for: Author "Motazacker, M." Remove constraint Author: "Motazacker, M." Search Limiters Full Text Remove constraint Search Limiters: Full Text
35 results on '"Motazacker, M."'

Search Results

1. Missense variants in DPYSL5 cause a neurodevelopmental disorder with corpus callosum agenesis and cerebellar abnormalities

3. Diagnostic utility and reporting recommendations for clinical DNA methylation episignature testing in genetically undiagnosed rare diseases

4. Exome Sequencing in Suspected Monogenic Dyslipidemias

5. Deficiency of TET3 leads to a genome-wide DNA hypermethylation episignature in human whole blood

6. Missense and truncating variants in CHD5 in a dominant neurodevelopmental disorder with intellectual disability, behavioral disturbances, and epilepsy

7. Mutations in NSUN2 Cause Autosomal- Recessive Intellectual Disability

8. Genotype-phenotype correlations in SCN8A-related disorders reveal prognostic and therapeutic implications

9. Clinicobiological characteristics and treatment efficacy of novel agents in chronic lymphocytic leukemia with IGLV3-21 R110.

10. Genotype-phenotype correlations in SCN8A-related disorders reveal prognostic and therapeutic implications

11. Clinicobiological characteristics and treatment efficacy of novel agents in chronic lymphocytic leukemia with IGLV3-21(R110)

12. Genotype-phenotype correlations in SCN8A-related disorders reveal prognostic and therapeutic implications

14. P609: CLINICOBIOLOGICAL CHARACTERISTICS AND TREATMENT EFFICACY OF NOVEL AGENTS IN CHRONIC LYMPHOCYTIC LEUKEMIA WITH IGLV3-21R110

15. Author Correction: Deficiency of TET3 leads to a genome-wide DNA hypermethylation episignature in human whole blood (npj Genomic Medicine, (2021), 6, 1, (92), 10.1038/s41525-021-00256-y)

16. Author Correction: Deficiency of TET3 leads to a genome-wide DNA hypermethylation episignature in human whole blood (npj Genomic Medicine, (2021), 6, 1, (92), 10.1038/s41525-021-00256-y):Deficiency of TET3 leads to a genome-wide DNA hypermethylation episignature in human whole blood (npj Genomic Medicine, (2021), 6, 1, (92), 10.1038/s41525-021-00256-y)

17. De novo and bi-allelic variants in AP1G1 cause neurodevelopmental disorder with developmental delay, intellectual disability, and epilepsy

18. Bi-allelic variants in DNA mismatch repair proteins MutS Homolog MSH4 and MSH5 cause infertility in both sexes

20. Genotype-phenotype correlations in SCN8A-related disorders reveal prognostic and therapeutic implications

21. Genotype-phenotype correlations in SCN8A-related disorders reveal prognostic and therapeutic implications

22. Genotype-phenotype correlations in SCN8A-related disorders reveal prognostic and therapeutic implications

23. Author Correction: Deficiency of TET3 leads to a genome-wide DNA hypermethylation episignature in human whole blood

24. Deficiency of TET3 leads to a genome-wide DNA hypermethylation episignature in human whole blood

25. Bi-allelic variants in DNA mismatch repair proteins MutS Homolog MSH4 and MSH5 cause infertility in both sexes.

26. BOD1 Is Required for Cognitive Function in Humans and Drosophila

27. Diagnostic utility and reporting recommendations for clinical DNA methylation episignature testing in genetically undiagnosed rare diseases

28. Zeolite Nanoparticles for Selective Sorption of Plasma Proteins

29. The cypriot and Iranian National Mutation Frequency Databases

32. ABCA1 mutation carriers with low high-density lipoprotein cholesterol are characterized by a larger atherosclerotic burden

33. Genotype-phenotype correlations in SCN8A-related disorders reveal prognostic and therapeutic implications

34. Exome sequencing in suspected monogenic dyslipidemias

35. Genotype-phenotype correlations in SCN8A-related disorders reveal prognostic and therapeutic implications.

Catalog

Books, media, physical & digital resources